cytidine diphosphate choline has been researched along with Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jamora, RDG; Que, DS | 1 |
| Saver, JL | 1 |
| Agnoli, A; Bruno, G; Denaro, A; Ruggieri, S | 1 |
| Frontera, G; Secades, JJ | 1 |
| Kish, SJ; Mamalias, N; Moszczynska, A; Rajput, AH; Ross, BM | 1 |
| Cubells, JM; Hernando, C | 1 |
3 review(s) available for cytidine diphosphate choline and Parkinson Disease
| Article | Year |
|---|---|
Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review.
Topics: Chemotherapy, Adjuvant; Cytidine Diphosphate Choline; Humans; Nootropic Agents; Parkinson Disease; Randomized Controlled Trials as Topic | 2021 |
Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.
Topics: Acetylcholine; Animals; Cell Membrane; Clinical Trials as Topic; Cognition Disorders; Craniocerebral Trauma; Cytidine Diphosphate Choline; Dopamine; Fatty Acids, Nonesterified; Glaucoma; Humans; Meta-Analysis as Topic; Nerve Regeneration; Neurons; Neuroprotective Agents; Optic Neuropathy, Ischemic; Parkinson Disease; Phospholipids; Stroke | 2008 |
CDP-choline: pharmacological and clinical review.
Topics: Animals; Biological Availability; Cerebrovascular Disorders; Craniocerebral Trauma; Cytidine Diphosphate Choline; Dementia; Humans; Nootropic Agents; Parkinson Disease; Tissue Distribution | 1995 |
1 trial(s) available for cytidine diphosphate choline and Parkinson Disease
| Article | Year |
|---|---|
Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease.
Topics: Choline; Clinical Trials as Topic; Cytidine Diphosphate Choline; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1988 |
2 other study(ies) available for cytidine diphosphate choline and Parkinson Disease
| Article | Year |
|---|---|
New strategies in the management of Parkinson's disease: a biological approach using a phospholipid precursor (CDP-choline).
Topics: Adult; Aged; Benserazide; Carbidopa; Choline; Cytidine Diphosphate Choline; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1982 |
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Cell Membrane; Choline-Phosphate Cytidylyltransferase; Cytidine Diphosphate Choline; Enzyme Activation; Ethanolamines; Female; Humans; Male; Oxidative Stress; Parkinson Disease; Phospholipases A; Phospholipases A2; Phospholipids; Phosphorylcholine; Substantia Nigra | 2001 |